| 2025-03-06 | -79.1% | news | Seeking Alpha | Aclarion announces expansion plans with RadNet affiliates in NY, NJ |
| 2025-03-06 | -79.1% | news | Investing.com | Aclarion stock hits 52-week low at $2.26 amid sharp annual decline - Investing.com |
| 2025-03-06 | -79.1% | news | StocksToTrade | Aclarion Shares Take a Dive: What’s Next? - StocksToTrade |
| 2024-02-26 | -60.9% | news | Seeking Alpha | Aclarion stock tumbles 63% on pricing of $3M public offering |
| 2024-02-26 | -60.9% | news | InvestorPlace | Why Is Aclarion (ACON) Stock Down 19% Today? - InvestorPlace |
| 2025-01-06 | -46.1% | legal | SEC EDGAR | ACON 8-K: 1.01, 7.01 (SEC Filing) |
| 2026-01-09 | -45.6% | legal | SEC EDGAR | ACON 8-K: 1.01 and (SEC Filing) |
| 2026-01-09 | -45.6% | news | Benzinga | Why Tilray Brands Shares Are Trading Higher By Over 7%; Here Are 20 Stocks Moving Premarket - Benzinga |
| 2024-02-21 | -29.1% | legal | SEC EDGAR | ACON 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-03-26 | -28.7% | news | Seeking Alpha | Aclarion looks to conduct reverse stock split |
| 2025-03-26 | -28.7% | news | Ortho Spine News | Aclarion Announces Reverse Stock Split - Ortho Spine News |
| 2025-03-26 | -28.7% | news | Investing.com | Aclarion stock plunges to 52-week low of $0.51 amid steep decline - Investing.com |
| 2024-08-13 | -27.4% | legal | SEC EDGAR | ACON 8-K: 1.01 and (SEC Filing) |
| 2025-01-28 | -26.7% | news | Investing.com | Aclarion announces revised reverse stock split details - Investing.com |
| 2025-01-28 | -26.7% | news | Investing.com | Aclarion stock plunges to 52-week low, touches $0.03 - Investing.com |
| 2025-01-30 | -24.3% | legal | SEC EDGAR | ACON 8-K: 3.03, 5.03, 8.01 (SEC Filing) |
| 2024-01-22 | -24.0% | news | Seeking Alpha | Aclarion files to sell 2.5M shares for its holder |
| 2023-04-24 | +23.0% | news | Seeking Alpha | Aclarion stock surges ~85% as Nociscan software shows benefit in disc surgeries |
| 2022-10-25 | +22.0% | legal | SEC EDGAR | ACON 8-K: 7.01 and 8.01 (SEC Filing) |
| 2025-01-31 | -19.6% | legal | SEC EDGAR | ACON 8-K: 1.01, 7.01 (SEC Filing) |
| 2023-06-08 | +19.4% | news | Seeking Alpha | Aclarion surges ~30% after cost-effectiveness data presentation for Nociscan software |
| 2024-08-12 | -19.1% | legal | SEC EDGAR | ACON 8-K: 1.01 and (SEC Filing) |
| 2024-01-23 | -18.4% | legal | SEC EDGAR | ACON 8-K: 1.01, 3.02 (SEC Filing) |
| 2026-01-08 | -17.5% | earnings | Seeking Alpha | Aclarion to enroll around 25% of patients in CLARITY trial by Q2 |
| 2026-01-08 | -17.5% | news | Stocktwits | ACON Stock Pops 45% Pre-Market Today: What’s Driving The Move? - Stocktwits |
| 2026-01-08 | -17.5% | news | Stock Titan | Back pain scans jump 69% as Aclarion extends its cash runway into 2027 - Stock Titan |
| 2026-01-08 | -17.5% | earnings | Investing.com | Aclarion stock soars on 114% jump in Q4 Nociscan scan volumes - Investing.com |
| 2026-01-08 | -17.5% | news | StocksToTrade | Aclarion Inc.: Analyzing the Sudden Surge - StocksToTrade |
| 2026-01-08 | -17.5% | news | Asianet Newsable | ACON Stock Pops 45% Pre-Market Today: What’s Driving The Move? - Asianet Newsable |
| 2026-01-08 | -17.5% | news | parameter.io | Aclarion, Inc., (ACON) stock: surges 39% as Nociscan adoption accelerates into 2026 - parameter.io |
| 2024-01-29 | -15.2% | legal | SEC EDGAR | ACON 8-K: 1.01 and 3.02 (SEC Filing) |
| 2022-04-27 | -14.2% | legal | SEC EDGAR | ACON 8-K: 1.01, 3.01, 5.03, 8.01 (SEC Filing) |
| 2022-09-09 | +13.6% | analyst | TradingView | ACON Forecast — Price Target — Prediction for 2027 - TradingView |
| 2024-01-08 | +12.8% | expansion | Seeking Alpha | Aclarion executes partnership with a unit of Alphatec |
| 2024-01-08 | +12.8% | news | CNN | symbol__ Stock Quote Price and Forecast - CNN |
| 2022-04-30 | -12.7% | earnings | MarketBeat | Aclarion (ACON) Stock Price, News & Analysis - MarketBeat |
| 2026-01-06 | +10.7% | news | Stock Titan | AI spine scan study expands as hospitals test new back pain surgery guide - Stock Titan |
| 2024-10-25 | -10.5% | news | Seeking Alpha | Aclarion files to sell 20M shares of common stocks by selling shareholders |
| 2026-04-09 | -10.0% | news | Cổng thông tin điện tử tỉnh Lào Cai | Will Aclarion (ACON) Stock Go Higher | Price at $3.80, Up 6.44% - Seasonal Patterns - Cổng thông tin điện tử tỉnh Lào Cai |
| 2023-11-22 | -9.8% | legal | SEC EDGAR | ACON 8-K: 1.01, 3.02 (SEC Filing) |
| 2024-08-29 | -9.7% | legal | SEC EDGAR | ACON 8-K: 1.01, 3.02 (SEC Filing) |
| 2024-08-29 | -9.7% | expansion | Stock Titan | Aclarion Launches Second Clinical Utility and Economic (CLUE) Trial Site With First Surgeon in New Jersey - Stock Titan |
| 2023-03-28 | -9.2% | legal | SEC EDGAR | ACON 8-K: 5.07 and 8.01 (SEC Filing) |
| 2023-09-01 | -8.6% | legal | SEC EDGAR | ACON 8-K: 1.01, 3.02 (SEC Filing) |
| 2023-05-23 | -8.5% | legal | SEC EDGAR | ACON 8-K: 2.02, 8.01 (SEC Filing) |
| 2023-12-20 | -8.5% | news | TradingView | Free float of Aclarion, Inc. – NASDAQ:ACON - TradingView |
| 2023-02-17 | +8.5% | legal | SEC EDGAR | ACON 8-K: 1.01, 3.02, 5.03 (SEC Filing) |
| 2026-04-22 | -8.3% | news | GlobeNewswire | Aclarion Announces $2.5 Million Stock Repurchase Plan |
| 2026-04-22 | -8.3% | news | Seeking Alpha | Aclarion announces $2.5M stock repurchase plan |
| 2026-04-22 | -8.3% | legal | SEC EDGAR | ACON 8-K: 8.01 and (SEC Filing) |
| 2026-04-22 | -8.3% | news | Stock Titan | With $19M cash, Aclarion plans buybacks while funding Nociscan - Stock Titan |
| 2026-04-22 | -8.3% | news | marketscreener.com | Aclarion Announces $2.5 Million Stock Repurchase Plan - marketscreener.com |
| 2026-04-22 | -8.3% | expansion | Stock Titan | Aclarion (NASDAQ: ACON) launches $2.5M share buyback plan - Stock Titan |
| 2023-12-12 | -7.9% | news | Seeking Alpha | Aclarion files to sell 25.93M units |
| 2025-09-19 | +7.7% | analyst | GuruFocus | ACON Stock: Analyst Boosts Price Target While Maintaining Buy Ra - GuruFocus |
| 2025-08-07 | -7.0% | news | Zacks Investment Research | Should I buy Aclarion (ACON) - Zacks Investment Research |
| 2025-12-04 | -7.0% | news | Quiver Quantitative | Aclarion, Inc. Stock (ACON) Opinions on Nociscan Technology Publication | ACON Stock News - Quiver Quantitative |
| 2026-01-13 | -6.6% | analyst | Quiver Quantitative | Aclarion, Inc. Secures $10.4 Million in Common-Stock Financing to Strengthen Balance Sheet and Extend Operating Runway - Quiver Quantitative |
| 2026-01-13 | -6.6% | news | Stock Titan | Debt-free Aclarion now holds $21.6M to grow its AI back pain tool - Stock Titan |
| 2026-01-13 | -6.6% | news | TradingView | Aclarion, Inc. Closes $10.4 Million Financing to Extend Cash Runway - TradingView |
| 2026-01-13 | -6.6% | news | Benzinga | What's Going On With Aclarion Stock Tuesday? - Aclarion (NASDAQ:ACON) - Benzinga |
| 2025-10-14 | -6.4% | legal | SEC EDGAR | ACON 8-K: 1.01 and (SEC Filing) |
| 2025-10-14 | -6.4% | news | Benzinga | Why Ericsson Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket - Benzinga |
| 2025-01-17 | -6.4% | legal | SEC EDGAR | ACON 8-K: 1.01 and (SEC Filing) |
| 2022-07-06 | -6.0% | news | ChartMill | ACON Stock Price, Quote & Chart | ACLARION INC (NASDAQ:ACON) - ChartMill |
| 2025-03-13 | -6.0% | legal | SEC EDGAR | ACON 8-K: 8.01 (SEC Filing) |
| 2025-03-13 | -6.0% | legal | Investing.com | Aclarion, Inc. secures compliance with Nasdaq equity rule - Investing.com |
| 2024-01-02 | +5.9% | news | Seeking Alpha | Aclarion announces reverse stock split |
| 2023-08-14 | -5.6% | legal | SEC EDGAR | ACON 8-K: 1.01, 3.03 (SEC Filing) |
| 2022-05-14 | -5.1% | news | Seeking Alpha | Stocks To Watch: Retail Heavyweights Report, Block And Moderna Events |
| 2026-04-20 | +5.0% | news | Cổng thông tin điện tử tỉnh Lào Cai | Aclarion (ACON) Stock Insider Buying (Eye on Rally) 2026-04-20 - Trend Analysis - Cổng thông tin điện tử tỉnh Lào Cai |
| 2026-04-20 | +5.0% | news | Xã Vĩnh Công | Aclarion (ACON) Stock Insider Buying (Eye on Rally) 2026-04-20 - Community Watchlist - Xã Vĩnh Công |
| 2026-04-03 | -5.0% | news | Stock Titan | Aclarion (NASDAQ: ACON) seeks stockholder approval to expand equity plan to 500,000 shares - Stock Titan |
| 2026-02-03 | -4.9% | news | Stock Titan | LA pain clinic adds Aclarion’s noninvasive alternative to spinal injections - Stock Titan |
| 2026-04-08 | -4.8% | expansion | GlobeNewswire | Aclarion Announces Agreement with Weill Cornell Medicine |
| 2026-04-08 | -4.8% | news | Stock Titan | Weill Cornell spine study adds Aclarion tool for chronic back pain - Stock Titan |
| 2022-08-30 | +4.6% | analyst | Zacks Investment Research | What is the current Price Target and Forecast for Aclarion (ACON) - Zacks Investment Research |
| 2026-04-16 | +4.5% | legal | GlobeNewswire | Aclarion Secures U.S. Patent Advancing Scalable, AI-Driven Assessment of Chronic Low Back Pain |
| 2026-04-16 | +4.5% | news | Stock Titan | New Aclarion patent targets faster, more consistent chronic back-pain scans - Stock Titan |
| 2024-08-16 | +4.5% | legal | SEC EDGAR | ACON 8-K: 1.01, 3.02 (SEC Filing) |
| 2026-03-17 | +4.2% | news | GlobeNewswire | Aclarion to Participate in the 38th Annual ROTH Conference, Highlighting Key 2026 Catalysts and Strong Balance Sheet |
| 2026-03-17 | +4.2% | news | Stock Titan | Back pain scan firm Aclarion meets investors at ROTH with no debt - Stock Titan |
| 2026-03-25 | -3.7% | news | Stock Titan | SEG Opportunity Fund (ACON) discloses 244,043 shares, 9.98% of Aclarion - Stock Titan |
| 2026-03-25 | -3.7% | analyst | GuruFocus | Aclarion (ACON): Analyst Lowers Price Target While Maintaining B - GuruFocus |
| 2024-10-01 | -3.5% | legal | SEC EDGAR | ACON 8-K: 1.01, 3.02 (SEC Filing) |
| 2023-08-25 | -3.5% | legal | SEC EDGAR | ACON 8-K: 2.02, 3.01, 8.01 (SEC Filing) |
| 2025-06-20 | -3.5% | legal | SEC EDGAR | ACON 8-K: 5.02 (SEC Filing) |
| 2026-03-24 | +3.3% | executive | ACCESS Newswire | Echo Lake Capital Calls for the Resignation of David Neal From the Board of Directors of Aclarion Inc. |
| 2026-03-24 | +3.3% | executive | Stock Titan | Echo Lake Capital Calls for the Resignation of David Neal From the Board of Directors of Aclarion Inc. - Stock Titan |
| 2025-02-04 | -3.2% | news | Yahoo Finance | Aclarion, Inc. (ACON) Showcases AI-Powered NOCISCAN for Chronic Back Pain Diagnosis at Selby Spine Conference - Yahoo Finance |
| 2025-01-16 | -3.1% | news | Intellectia AI | ACON Stock: Price, Forecast, Financials & AI Analysis - Intellectia AI |
| 2023-05-16 | -2.8% | legal | SEC EDGAR | ACON 8-K: 2.02, 4.02 (SEC Filing) |
| 2024-06-26 | +2.8% | legal | SEC EDGAR | ACON 8-K: 1.01 and (SEC Filing) |
| 2025-10-13 | +2.7% | news | Stock Titan | 266M with low back pain — Aclarion Nociscan MR spectroscopy + AI identifies painful discs at ISPN - Stock Titan |
| 2025-10-13 | +2.7% | news | Benzinga | Why NioCorp Developments Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket - Benzinga |
| 2024-02-27 | +2.5% | legal | SEC EDGAR | ACON 8-K: 1.01, 8.01 (SEC Filing) |
| 2026-04-14 | -2.3% | news | GlobeNewswire | Aclarion Receives Pinnacle Award for AI Innovation |
| 2026-04-14 | -2.3% | legal | Stock Titan | AI tool for chronic back pain earns Aclarion a second health tech award - Stock Titan |
| 2023-05-17 | -2.2% | legal | SEC EDGAR | ACON 8-K: 1.01, 3.02 (SEC Filing) |
| 2026-04-07 | +2.1% | news | GlobeNewswire | Aclarion Highlights Growing Adoption of Nociscan at The London Clinic with New Physician Video |
| 2026-04-07 | +2.1% | news | Stock Titan | Aclarion says one London clinic has used its back-pain scan nearly 100 times - Stock Titan |
| 2026-04-07 | +2.1% | news | Cổng thông tin điện tử tỉnh Lào Cai | Is Aclarion (ACON) Stock Declining | Price at $3.56, Up 4.40% - Buy Zone Stocks - Cổng thông tin điện tử tỉnh Lào Cai |
| 2024-11-04 | -2.1% | news | Seeking Alpha | Aclarion files to sell 27.52M shares of common stock for holders |
| 2023-05-19 | -2.1% | news | Seeking Alpha | Aclarion gets $2M debt financing |
| 2026-03-19 | -1.7% | news | GlobeNewswire | Aclarion, Inc. Adopts Limited Duration Stockholder Rights Plan |
| 2026-03-19 | -1.7% | executive | GlobeNewswire | Aclarion Publishes CEO Shareholder Letter Highlighting Strategic Progress and 2026 Catalysts |
| 2026-03-19 | -1.7% | legal | SEC EDGAR | ACON 8-K: 1.01, 3.03, 5.03, 8.01 (SEC Filing) |
| 2026-03-19 | -1.7% | news | Stock Titan | Aclarion targets US insurers as back-pain trial readout nears - Stock Titan |
| 2026-03-19 | -1.7% | earnings | Stock Titan | Aclarion installs 1-year takeover defense, keeps door open to fair bids - Stock Titan |
| 2026-03-19 | -1.7% | news | TipRanks | Aclarion Adopts One-Year Stockholder Rights Protection Plan - TipRanks |
| 2023-04-05 | +1.4% | news | CoinCodex | Aclarion, Inc. (ACON) Stock Forecast & Price Prediction 2026–2030 - CoinCodex |
| 2026-02-05 | +1.2% | news | Stock Titan | No new funding planned as Aclarion awaits back pain trial data in 2026 - Stock Titan |
| 2026-03-12 | -1.1% | executive | GlobeNewswire | Aclarion CEO Brent Ness to Attend LSI USA 2026 |
| 2026-03-12 | -1.1% | news | Stock Titan | Back pain imaging firm Aclarion courts partners at LSI USA 2026 - Stock Titan |
| 2023-10-10 | -0.9% | legal | SEC EDGAR | ACON 8-K: 1.01, 3.02 (SEC Filing) |
| 2024-11-27 | -0.9% | legal | SEC EDGAR | ACON 8-K: 1.01, 3.02 (SEC Filing) |
| 2025-09-03 | +0.7% | executive | Seeking Alpha | Aclarion taps Greg Gould as CFO |
| 2025-09-03 | +0.7% | legal | SEC EDGAR | ACON 8-K: 1.01, 5.02, 7.01 (SEC Filing) |
| 2025-12-02 | +0.7% | news | Stock Titan | Aclarion (Nasdaq: ACON) hires Jason Brosniak to expand Nociscan adoption in Eastern U.S. - Stock Titan |
| 2024-09-24 | +0.5% | legal | SEC EDGAR | ACON 8-K: 1.01 and (SEC Filing) |
| 2025-02-11 | +0.5% | news | Seeking Alpha | Aclarion receives U.S. patent on expanded applications of MRS data processing |
| 2023-10-29 | +0.0% | earnings | TradingView | Aclarion, Inc. Earnings and Revenue – NASDAQ:ACON - TradingView |
| 2022-04-22 | — | news | TradingView | ACON Stock Price and Chart — NASDAQ:ACON - TradingView |
| 2022-04-22 | — | news | Stock Titan | Latest ACON News - Aclarion Announces $2.5 Million Stock Repur... - Stock Titan |